Presentation
13 March 2024 Use of multiplexed optical detection techniques to elucidate anti-tumor immune responses in human basal cell carcinomas (BCC) treated with photodynamic therapy
Author Affiliations +
Abstract
Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) holds great promise as a treatment option for human basal cell carcinoma (BCC), the most common of all cancers. Recent evidence suggests that PDT is an immune-altering modality. Here we describe a clinical trial (NCT05020912) to examine the effects of ALA-PDT upon the tumor immune landscape within BCC tumors pre- and post-treatment, to better understand the nature of the tumor-infiltrating immune cells, and accompanying changes in systemic anti-tumor immunity. If better understood, such knowledge could be harnessed to improve therapeutic responses to PDT.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Edward V. Maytin, Alan Shen, Lauren Heusinkveld, Jackson Hanna, Sanjay Anand, Judy Drazba, Claudia Marcela Diaz-Montero, and Haidong Dong "Use of multiplexed optical detection techniques to elucidate anti-tumor immune responses in human basal cell carcinomas (BCC) treated with photodynamic therapy", Proc. SPIE PC12823, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXXII, PC1282305 (13 March 2024); https://doi.org/10.1117/12.3021791
Advertisement
Advertisement
Back to Top